Terry Heiman-Patterson, MD, Professor of Neurology at the Lewis Katz School of Medicine at Temple University, offered insight to Reuters Health about a study published in Nature Medicine that increases in brain perivascular fibroblasts and their protein SPP1 may better predict life expectancy in patients with sporadic amyotrophic lateral sclerosis, or ALS. Dr. Heiman-Patterson was not involved in the study. MD Alert picked up the Reuters Health article.
Weather Alert: A major winter storm is likely to impact the Philadelphia region this weekend into Monday. Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check TempleHealth.org for updates and monitor myTempleHealth for changes to scheduled appointments.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH